Gotowa bibliografia na temat „Jak2-Stat3”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Jak2-Stat3”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Artykuły w czasopismach na temat "Jak2-Stat3"
Zhou, Zehua, Ying Chen, Wenmin Dong, Rui An, Kun Liang, and Xinhong Wang. "Da Cheng Qi Decoction Alleviates Cerulein-Stimulated AR42J Pancreatic Acinar Cell Injury via the JAK2/STAT3 Signaling Pathway." Evidence-Based Complementary and Alternative Medicine 2021 (April 9, 2021): 1–13. http://dx.doi.org/10.1155/2021/6657036.
Pełny tekst źródłaJin, Wenyin, and Yinfeng Shen. "Da-Cheng-Qi Decoction Alleviates Intestinal Injury in Rats with Severe Acute Pancreatitis by Inhibiting the JAK2-STAT3 Signaling Pathway." Evidence-Based Complementary and Alternative Medicine 2019 (August 14, 2019): 1–12. http://dx.doi.org/10.1155/2019/3909468.
Pełny tekst źródłaHofmann, Hans-Dieter, and Matthias Kirsch. "JAK2-STAT3 signaling." JAK-STAT 1, no. 3 (2012): 191–93. http://dx.doi.org/10.4161/jkst.20446.
Pełny tekst źródłaKim, Hyunkyung, Dongha Kim, Seon Ah Choi, et al. "KDM3A histone demethylase functions as an essential factor for activation of JAK2−STAT3 signaling pathway." Proceedings of the National Academy of Sciences 115, no. 46 (2018): 11766–71. http://dx.doi.org/10.1073/pnas.1805662115.
Pełny tekst źródłaBouaouiche, Sarra, Silvia Ghione, Randa Sghaier, et al. "Nitric Oxide-Releasing Drug Glyceryl Trinitrate Targets JAK2/STAT3 Signaling, Migration and Invasion of Triple-Negative Breast Cancer Cells." International Journal of Molecular Sciences 22, no. 16 (2021): 8449. http://dx.doi.org/10.3390/ijms22168449.
Pełny tekst źródłaBarber, Ruth, Jenny Zobel, Daniel Beck, et al. "JAK2 Is a Direct BCL6 Target Gene: Implications for Therapy in Diffuse Large B-Cell Lymphoma." Blood 124, no. 21 (2014): 3112. http://dx.doi.org/10.1182/blood.v124.21.3112.3112.
Pełny tekst źródłaLi, Yun-Qing. "Down-Regulation of Insulin Signaling Is Involved in Painful Diabetic Neuropathy in Type 2 Diabetes." Pain Physician 2;16, no. 2;3 (2013): E71—E83. http://dx.doi.org/10.36076/ppj.2013/16/e71.
Pełny tekst źródłaLei, Bo, Ju Bai, Wanggang Zhang, et al. "Acute Monocytic Leukemia Associated Antigen MLAA-34 up-Regulates JAK2/STAT3 Expression and JAK2/STAT3 Enhances MLAA-34 Activation in a Positive Feedback Loop." Blood 126, no. 23 (2015): 1393. http://dx.doi.org/10.1182/blood.v126.23.1393.1393.
Pełny tekst źródłaZhang, Xuekang, Jun Zhou, Qian Hu, et al. "The Role of Janus Kinase/Signal Transducer and Activator of Transcription Signalling on Preventing Intestinal Ischemia/Reperfusion Injury with Dexmedetomidine." Journal of Nanoscience and Nanotechnology 20, no. 5 (2020): 3295–302. http://dx.doi.org/10.1166/jnn.2020.16416.
Pełny tekst źródłaLiu, Fa-Yu, Jawad Safdar, Zhen-Ning Li, et al. "CCR7 Regulates Cell Migration and Invasion through JAK2/STAT3 in Metastatic Squamous Cell Carcinoma of the Head and Neck." BioMed Research International 2014 (2014): 1–11. http://dx.doi.org/10.1155/2014/415375.
Pełny tekst źródłaRozprawy doktorskie na temat "Jak2-Stat3"
Wang, Kepeng. "The involvement of JAK2/STAT2/STAT3 in myogenic differentiation /." View abstract or full-text, 2008. http://library.ust.hk/cgi/db/thesis.pl?BICH%202008%20WANGK.
Pełny tekst źródłaStudd, James. "The role of JAK2, STAT3 and ERBB2 in ovarian cancer." Thesis, Imperial College London, 2013. http://hdl.handle.net/10044/1/24443.
Pełny tekst źródłaPoulot, Yiannis. "Hétérogénéité et régulation des astrocytes dans la maladie d'Alzheimer : vers des interventions ciblées sur les voies JAK2-STAT3 et NF-kB." Electronic Thesis or Diss., université Paris-Saclay, 2024. http://www.theses.fr/2024UPASL060.
Pełny tekst źródłaHernández, Ribes Gracia. "ESTUDIO DE LA RUTA CELULAR JAK2/STAT3 COMO POTENCIAL INHIBIDOR EN EL MODELO DE FIBROSIS PULMONAR." Doctoral thesis, Universitat Politècnica de València, 2016. http://hdl.handle.net/10251/64087.
Pełny tekst źródłaJark, Paulo César [UNESP]. "Estudo da via jak2/stat3 e de seus inibidores em linfomas multicêntricos difusos de grandes células B caninos." Universidade Estadual Paulista (UNESP), 2016. http://hdl.handle.net/11449/146685.
Pełny tekst źródłaJark, Paulo César. "Estudo da via jak2/stat3 e de seus inibidores em linfomas multicêntricos difusos de grandes células B caninos /." Jaboticabal, 2016. http://hdl.handle.net/11449/146685.
Pełny tekst źródłaBen, Haim Lucile. "Modulation of the JAK2/STAT3 pathway in vivo : understanding reactive astrocyte functional features and contribution to neurodegenerative diseases." Thesis, Paris 6, 2014. http://www.theses.fr/2014PA066534/document.
Pełny tekst źródłaYerabolu, Naga Dinesh Reddy [Verfasser]. "Inhibition of the JAK2-STAT3 pathway using ruxolitinib as a therapeutic option for pulmonary hypertension / Naga Dinesh Reddy Yerabolu." Gießen : Universitätsbibliothek, 2020. http://d-nb.info/1223462145/34.
Pełny tekst źródłaCeyzériat, Kelly. "Modulation de la réactivité astrocytaire par ciblage de la voie JAK2-STAT3 : conséquences dans des modèles murins de la maladie d’Alzheimer." Thesis, Université Paris-Saclay (ComUE), 2017. http://www.theses.fr/2017SACLS556/document.
Pełny tekst źródłaEtter, Jonathan Parker. "Development of Inhibitors in the IL-6/GP130/JAK/STAT Pathway as Therapeutic Agents." The Ohio State University, 2013. http://rave.ohiolink.edu/etdc/view?acc_num=osu1376525461.
Pełny tekst źródłaCzęści książek na temat "Jak2-Stat3"
Wu, Ruifan, and Xinxia Wang. "SOCS3/JAK2/STAT3 pathway in iPSCs." In Molecular Players in iPSC Technology. Elsevier, 2022. http://dx.doi.org/10.1016/b978-0-323-90059-1.00009-9.
Pełny tekst źródłaDemir Çetinkaya, Büşra. "Targeting the SH2 Domain of STAT3 Proteins in Breast Cancer Treatment." In Current Researches in Health Sciences-II. Özgür Yayınları, 2023. http://dx.doi.org/10.58830/ozgur.pub128.c630.
Pełny tekst źródłaNawwaf Al-Harithy, Rowyda. "Adipocytokines: Are They the Theory of Cancer Progression?" In Tumor Angiogenesis [Working Title]. IntechOpen, 2022. http://dx.doi.org/10.5772/intechopen.104581.
Pełny tekst źródłaCentonze, Giorgia, Jennifer Chapelle, Costanza Angelini, et al. "The Scaffold Protein p140Cap as a Molecular Hub for Limiting Cancer Progression: A New Paradigm in Neuroblastoma." In Pheochromocytoma, Paraganglioma and Neuroblastoma. IntechOpen, 2021. http://dx.doi.org/10.5772/intechopen.96383.
Pełny tekst źródłaLi, Xiao-Juan, Qing-Yu Ma, You-Ming Jiang, et al. "Xiaoyaosan Exerts Anxiolytic-like Effects by Down-regulating the TNF-α/JAK2-STAT3 Pathway in the Rat Hippocampus." In Insights into the Prevention and Treatment of Depression with Famous TCM Prescription Xiaoyaosan. B P International (a part of SCIENCEDOMAIN International), 2023. http://dx.doi.org/10.9734/bpi/mono/978-81-19315-94-9/ch13.
Pełny tekst źródłaStreszczenia konferencji na temat "Jak2-Stat3"
Gritsina, Galina, Fang Xiao, Shane W. O'Brien, et al. "Abstract 1113: Targeting the JAK2/STAT3 pathway in ovarian cancer." In Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA. American Association for Cancer Research, 2014. http://dx.doi.org/10.1158/1538-7445.am2014-1113.
Pełny tekst źródłaOvermoyer, BA, V. Almendro, S. Shu, et al. "Abstract P4-06-01: JAK2/STAT3 activity in inflammatory breast cancer supports the investigation of JAK2 therapeutic targeting." In Abstracts: Thirty-Fifth Annual CTRC‐AACR San Antonio Breast Cancer Symposium‐‐ Dec 4‐8, 2012; San Antonio, TX. American Association for Cancer Research, 2012. http://dx.doi.org/10.1158/0008-5472.sabcs12-p4-06-01.
Pełny tekst źródłaBallester, Beatriz, Javier Milara, Anselm Morell, et al. "Role of JAK2/STAT3 pathway in vascular function of pulmonary fibrosis patients." In Annual Congress 2015. European Respiratory Society, 2015. http://dx.doi.org/10.1183/13993003.congress-2015.pa4902.
Pełny tekst źródłaChou, JC, PS Wang, SW Wang, and H. Lin. "PO-183 Prolactin activation of JAK2/STAT3 signalling pathway through GHR in NSCLC." In Abstracts of the 25th Biennial Congress of the European Association for Cancer Research, Amsterdam, The Netherlands, 30 June – 3 July 2018. BMJ Publishing Group Ltd, 2018. http://dx.doi.org/10.1136/esmoopen-2018-eacr25.704.
Pełny tekst źródłaJhaveri, K., E. Teplinsky, R. Arzu, et al. "Abstract PD5-6: Sustained hyperactivated mTOR & JAK2/STAT3 pathways in inflammatory breast cancer (IBC): Evidence for mTOR plus JAK2 therapeutic targeting." In Abstracts: Thirty-Sixth Annual CTRC-AACR San Antonio Breast Cancer Symposium - Dec 10-14, 2013; San Antonio, TX. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/0008-5472.sabcs13-pd5-6.
Pełny tekst źródłaHarada, Daijiro, Daijiro Harada, Nagio Takigawa, et al. "Abstract 717: JAK2/STAT3 induces erlotinib-resistance in lung cancer cells harboring EGFR-activating mutations." In Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL. American Association for Cancer Research, 2011. http://dx.doi.org/10.1158/1538-7445.am2011-717.
Pełny tekst źródłaSu, Wen-Pin, Ya-Chin Lo, Chien-Chung Lin, Helen H. W. Chen, Wu-Wei Lai, and Wu-Chou Su. "Abstract 1636: Anticancer drug-induced Jak2/Stat3 activation confers a survival advantage in lung cancer cells." In Proceedings: AACR 101st Annual Meeting 2010‐‐ Apr 17‐21, 2010; Washington, DC. American Association for Cancer Research, 2010. http://dx.doi.org/10.1158/1538-7445.am10-1636.
Pełny tekst źródłaNam, Sangkil, Jun Xie, Angela Perkins, et al. "Abstract 864: Novel synthetic berbamine derivatives inhibit Jak2/Stat3 signaling and induce apoptosis of human melanoma cells." In Proceedings: AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012; Chicago, IL. American Association for Cancer Research, 2012. http://dx.doi.org/10.1158/1538-7445.am2012-864.
Pełny tekst źródłaJia, Zhenxian, Zhi Zhang, Ze Li, et al. "Abstract 4051: Anlotinib inhibits the progress of colorectal cancer cells by antagonizing glycolysis & JAK2-STAT3 signaling." In Proceedings: AACR Annual Meeting 2020; April 27-28, 2020 and June 22-24, 2020; Philadelphia, PA. American Association for Cancer Research, 2020. http://dx.doi.org/10.1158/1538-7445.am2020-4051.
Pełny tekst źródłaNagathihalli, Nagaraj, Yugandhar Beesetty, Michelle Reyzer, Chanjuan Shi, Richard Caprioli, and Nipun Merchant. "Abstract B32: JAK2 inhibition blocks STAT3 signaling and enhances drug delivery and therapeutic response in pancreatic cancer." In Abstracts: AACR Special Conference on Pancreatic Cancer: Progress and Challenges; June 18-21, 2012; Lake Tahoe, NV. American Association for Cancer Research, 2012. http://dx.doi.org/10.1158/1538-7445.panca2012-b32.
Pełny tekst źródła